Matthew Kulke

8PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursCancer diagnosisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 20, 2025
Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Kimberly J Perez, Nora Horick, Joanna Baginksa

|Sep 05, 2024
Diagnosis and Management of Parathyroid Carcinoma.

Alexander Lazzaro, Grace Qing Zhao, Matthew Kulke

|Oct 19, 2022
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

Pamela L Kunz, Noah T Graham, Paul J Catalano

|Jun 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma.

Kimberly Perez, Heather Jacene, Jason L Hornick

Pageof 2